Literature DB >> 14967789

Elliptical excisions: variations and the eccentric parallelogram.

Leonard H Goldberg1, Murad Alam.   

Abstract

BACKGROUND: The elliptical (fusiform) excision is a basic tool of cutaneous surgery.
OBJECTIVE: To assess the design, functionality, ease of construction, and aesthetic outcomes of the ellipse.
DESIGN: A systematic review of elliptical designs and their site-specific benefits and limitations. In particular, we consider the (1). context of prevailing relaxed skin tension lines and tissue laxity; and (2). removal of the smallest possible amount of tissue around the lesion and in the "dog-ears." Attention is focused on intuitive methods that can be reproducibly planned and executed.
RESULTS: Elliptical variations are easily designed and can be adapted to many situations. The eccentric parallelogram excision is offered as a new technique that minimizes notching and focal tension in the center of an elliptical closure. Conclusion The elliptical (fusiform) excision is an efficient, elegant, and versatile technique that will remain a mainstay of the cutaneous surgical armamentarium.

Entities:  

Mesh:

Year:  2004        PMID: 14967789     DOI: 10.1001/archderm.140.2.176

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

1.  Simulation-based cutaneous surgical-skill training on a chicken-skin bench model in a medical undergraduate program.

Authors:  Rafael Denadai; Rogério Saad-Hossne; Luís Ricardo Martinhão Souto
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

2.  Basic Plastic Surgery Skills Training Program on Inanimate Bench Models during Medical Graduation.

Authors:  Rafael Denadai; Andréia Padilha Toledo; Luis Ricardo Martinhão Souto
Journal:  Plast Surg Int       Date:  2012-12-30

3.  Teaching elliptical excision skills to novice medical students: a randomized controlled study comparing low- and high-fidelity bench models.

Authors:  Rafael Denadai; Marie Oshiiwa; Rogério Saad-Hossne
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.